Drug
Docetaxel Plus Capecitabine
Docetaxel Plus Capecitabine: highest development phase Phase 3, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| Docetaxel plus Capecitabine NCT01917279 | Phase 3 | Breast Neoplasms |
Latest
No recent events.
Follow Docetaxel Plus Capecitabine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.